Phase 3 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 21 and 65 years old
- People who have been diagnosed with schizophrenia or schizoaffective disorder
- People who have been experiencing significant and ongoing negative symptoms (such as reduced motivation, emotional flatness, or withdrawal) for the past 6 months, as measured by standard clinical rating scales
- People whose positive symptoms (such as hallucinations or delusions) are not considered clinically significant, based on standard assessment scores
- People whose depression symptoms are not considered clinically significant, based on a standard depression rating scale for schizophrenia
- People who are able to give informed consent to participate
Who may not be able to join:
- People who are currently misusing or dependent on illegal drugs or alcohol
- People who are considered to be at high risk of suicide
- People who have a history of epileptic seizures
- People who have had a severe brain injury or trauma, or who have another neurological condition
- People who have any metal implants in the skull
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 6389 2000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change of Negative symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.